Chronic Myelomonocytic Leukemia Completed Phase Trials for Valganciclovir (DB01610)

Also known as: Chronic myelomonocytic leukaemia / Chronic myelomonocytic leukemia with failed remission / Leukemia, Myelomonocytic, Chronic

IndicationStatusPhase
DBCOND0028572 (Chronic Myelomonocytic Leukemia)CompletedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01199562Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell TransplantSupportive Care